Evidence map›Paper›PMID 38953008›Full record

ArticleOpen medicine (Warsaw, Poland)2024

Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with

Liang Hu, Lina Li, Angcheng Li, Jianyong Tong

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Open medicine (Warsaw, Poland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liang HuDepartment of Urology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Lina LiCollege of Medicine, Jinhua Polytechnic, Jinhua, Zhejiang, China.
Angcheng LiDepartment of Pathology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Jianyong TongDepartment of Urology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Renal cell carcinoma (RCC) with Case presentation: A case of RCC with Xp11.2 RCC translocations and Conclusion: Our study highlights the natural course, diagnosis, and treatment of RCC-associated Xp11.2 translocation/TFE3 gene fusions, especially the necessity of early surgery. This case may be a helpful reference for urologists in the treatment of similar cases. It also serves as a precautionary signal for patients who neglect the renal neoplasm.

Indexed as

natural progressive courseradical nephrectomyrenal cell carcinomaTFE3Xp11.2 translocations

Identifiers

PMID38953008
PMCPMC11215303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.